Neuroalojen ja kuntoutuksen vastuualue

Julkaisut 2016 (alustava)
Publications 2016 (preliminary)

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Alapirtti T et al. The concentration of cell-free DNA in video-EEG patients is dependent on the epilepsy syndrome and duration of epilepsy.
2 Boogaard van Den M et al. Mutations in DNMT3B Modify Epigenetic Repression of the D4Z4 Repeat and the Penetrance of Facioscapulohumeral Dystrophy .
3 Evangelista T et al. 215th ENMC International Workshop VCP-related multi-system proteinopathy (IBMPFD) 13-15 November 2015, Heemskerk, The Netherlands.
4 Evilä A et al. Targeted next-generation sequencing assay for detection of mutations in primary myopathies.
5 Freyermuth F et al. Splicing misregulation of SCN5A contributes to cardiac-conduction delay and heart arrhythmia in myotonic dystrophy.
6 Ghaoui R et al. Mutations in HSPB8 causing a new phenotype of distal myopathy and motor neuropathy.
7 Heikkinen V. Pitkäaikaistyötön vai pysyvästi työkyvytön.
8 Huovinen J et al. Familial idiopathic normal pressure hydrocephalus.
9 Hämäläinen P, Rosti-Otajärvi E. Cognitive impairment in MS: rehabilitation approaches.
10 Hänninen T et al. Sport concussion assessment tool - 3rd edition - normative reference values for professional ice hockey players .
11 Isokuortti H et al. Who Gets Head Trauma or Recruited in Mild Traumatic Brain Injury Research?
12 Jiltsova E et al. Imaging of Anterior Nucleus of Thalamus Using 1.5T MRI for Deep Brain Stimulation Targeting in Refractory Epilepsy.
13 Jokela M et al. Distinct Muscle Biopsy Findings in Genetically Defined Adult-Onset Motor Neuron Disorders.
14 Jokela ME, Udd B. Diagnostic Clinical, Electrodiagnostic and Muscle Pathology Features of Spinal and Bulbar Muscular Atrophy.
15 Kaur A et al. PP2A Inhibitor PME-1 Drives Kinase Inhibitor Resistance in Glioma Cells.
16 Kiiski H et al. Increased plasma UCH-L1 after aneurysmal subarachnoid hemorrhage is associated with unfavorable neurological outcome.
17 Kok E et al. Beer Drinking Associates with Lower Burden of Amyloid Beta Aggregation in the Brain: Helsinki Sudden Death Series.
18 Kuusisto H et al. Asymptomatic subjects differ less from their twin siblings with MS than from healthy controls in cognitive functioning. A Finnish Twin Cohort study.
19 Lehtimäki K et al. Outcome based definition of the anterior thalamic deep brain stimulation target in refractory epilepsy.
20 Liimatainen J et al. Improved cognitive flexibility after aortic valve replacement surgery.
21 Liimatainen S et al. Aivovammojen ali- ja ylidiagnostiikka.
22 Losoi H et al. Recovery from Mild Traumatic Brain Injury in Previously Healthy Adults.
23 Luoto T, Tenovuo O. Pohjoismainen hoitosuositus avuksi pään vammojen arviointiin.
24 Långsjö J et al. Critical neural targets for (the level of) human consciousness: Arousal arrest and unconsciousness after sumatriptan administration.
25 Makkonen T et al. Oral motor functions, speech and communication before a definitive diagnosis of amyotrophic lateral sclerosis.
26 Mattila E et al. Organisaatiokulttuurin eettisyys yliopistosairaalassa.
27 Möttönen T et al. The Correlation between Intraoperative Microelectrode Recording and 3-Tesla MRI in Patients Undergoing ANT-DBS for Refractory Epilepsy.
28 Numminen S et al. Factors Influencing Quality of Life Six Months after a First-Ever Ischemic Stroke: Focus on Thrombolyzed Patients.
29 Evilä A et al. Re-evaluation of the phenotype caused by the common MATR3 p.Ser85Cys mutation in a new family.
30 Palmio J et al. Distaaliset myopatiat - laajeneva kirjo erilaisia tauteja myös Suomessa.
31 Palmio J et al. Novel compound heterozygous mutation in SACS gene leads to a milder autosomal recessive spastic ataxia of Charlevoix-Saguenay, ARSACS, in a Finnish family.
32 Palmio J, Udd B. Myofibrillar and distal myopathies.
33 Palmio J et al. CSF and plasma adipokines after tonic-clonic seizures.
34 Palomäki S, Vanhala A. Terveydenhuollon muistutus asiakkaan arvioimana käytäntönä.
35 Palomäki S, Vanhala A. Patients’ Complaints and Managers’ Responses as a Process of Institutional Interaction.
36 Palomäki S, Vanhala A. Patients’ Complaints and Managers’ Responses as a Process of Institutional Interaction.
37 Palomäki S, Vanhala A. Mihin potilaat ovat tyytymättömiä.
38 Palomäki S, Vanhala A. Patients' Complaints and Managers' Responses as a Process of Institutional Interaction.
39 Papadimas G et al. GNE-Myopathy in a Greek Romani Family with Unusual Calf Phenotype and Protein Aggregation Pathology.
40 Pareyson D et al. Towards a European Registry and Biorepository for Patients with Spinal and Bulbar Muscular Atrophy.
41 Piirilä P et al. Unique Exercise Lactate Profile in Muscle Phosphofructokinase Deficiency (Tarui Disease); Difference Compared with McArdle Disease.
42 Protto S et al. Stent Retriever Thrombectomy in Different Thrombus Locations of Anterior Cerebral Circulation.
43 Puumalainen A et al. Health outcomes and costs of ischemic stroke patients in Finland.
44 Pyysalo MJ et al. Bacterial DNA findings in ruptured and unruptured intracranial aneurysms.
45 Rainesalo S et al. Sairaanhoitajan vastaanotolle on kysyntää neurologian poliklinikalla.
46 Raj R et al. Traumatic brain injury patient volume and mortality in neurosurgical intensive care units: a Finnish nationwide study.
47 Rudolf G et al. Homozygosity of the dominant myotilin c.179C>T (p.Ser60Phe) mutation causes a more severe and proximal muscular dystrophy.
48 Sandell S et al. Diagnostically important muscle pathology in DNAJB6 mutated LGMD1D.
49 Savarese M et al. The genetic basis of undiagnosed muscular dystrophies and myopathies: results from 504 patients.
50 Savarese M et al. Increasing Role of Titin Mutations in Neuromuscular Disorders.
51 Sun L. Impact pf Neuromodulation on Cognitive and Affective Brain Functions in Humans.
52 Sun L et al. Human Brain Reacts to Transcranial Extraocular Light.
53 Suomalainen P et al. Traumakäsikirja, Vaikeasti vammautuneen potilaan hoito Taysissa 2016.
54 Sätilä H et al. Hirayaman tauti.
55 Tasca G et al. Start codon mutation of GYG1 causing late-onset polyglucosan body myopathy with nemaline rods.
56 Thesleff T et al. Fatal cervical spine injuries: a Finnish nationwide register-based epidemiologic study on data from 1987 to 2010.
57 Tomson T et al. Withdrawal of valproic acid treatment during pregnancy and seizure outcome: Observations from EURAP.
58 Vanhala A et al. Kuntoutumista tukeva työote.
Julkaisutietokanta 19.10.2017 Publications Data Base 19.10.2017